Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026

Amphstar Pharmaceuticals, Inc. (AMPH)

Nasdaq Health Care Pharmaceuticals S&P SmallCap 600
$28.49
+0.83 (+3.00%)
Close of Nov 06, 2026 · end-of-day data
Source: Amphstar Pharmaceuticals, Inc.'s 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$255.16M$240.18M$294.67M$322.36M$349.85M$437.77M$498.99M$644.39M$731.97M$719.89M
Cost of revenue$150.97M$149.67M$187.68M$190.43M$206.51M$238.03M$250.13M$293.27M$358.11M$363.83M
Gross profit$104.20M$90.51M$106.98M$131.92M$143.34M$199.74M$248.86M$351.12M$373.86M$356.06M
Research & development$41.52M$43.50M$57.56M$68.85M$67.23M$60.93M$74.77M$73.74M$73.91M$85.84M
Operating income$15.38M-$1.27M-$8.62M-$39.00K$10.95M$69.89M$107.50M$196.99M$205.42M$140.40M
Interest expense$1.02M$826.00K$243.00K$119.00K$374.00K$885.00K$1.85M$27.16M$30.34M$25.48M
Pre-tax income$14.63M$1.25M-$9.93M$60.23M$4.64M$84.14M$116.04M$171.36M$189.76M$123.62M
Income tax$4.81M-$2.40M-$3.27M$13.72M$3.54M$20.63M$23.48M$31.83M$29.67M$25.53M
Net income$9.82M$3.65M-$5.74M$48.94M$1.40M$62.12M$91.39M$137.54M$159.52M$98.09M
EBITDA$27.54M$5.15M-$2.57M$7.02M$19.98M$80.11M$120.09M$222.72M$233.67M$172.05M
EPS (basic)$0.22$0.08$-0.12$1.04$0.03$1.30$1.88$2.85$3.29$2.10
EPS (diluted)$0.21$0.08$-0.12$0.98$0.03$1.25$1.74$2.60$3.06$2.03
Diluted shares47.50M48.37M46.40M49.91M49.12M49.78M52.43M53.00M52.06M48.22M
Gross margin40.8%37.7%36.3%40.9%41.0%45.6%49.9%54.5%51.1%49.5%
Operating margin6.0%-0.5%-2.9%-0.0%3.1%16.0%21.5%30.6%28.1%19.5%
Net margin3.8%1.5%-1.9%15.2%0.4%14.2%18.3%21.3%21.8%13.6%

Balance sheet

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$72.35M$65.59M$86.34M$73.69M$92.64M$126.35M$156.10M$144.30M$151.61M$170.18M
Short-term investments$527.00K$2.63M$2.83M$11.68M$12.98M$10.32M$19.66M$112.51M$70.04M$112.64M
Receivables$26.78M$36.00M$52.16M$45.38M$66.00M$78.80M$88.80M$114.94M$136.29M$143.56M
Inventory$79.75M$63.61M$69.32M$110.50M$96.83M$92.81M$103.58M$105.83M$153.74M$176.89M
Total current assets$184.10M$187.78M$220.34M$255.24M$279.68M$318.12M$378.32M$489.60M$534.07M$636.02M
Goodwill$3.98M$4.46M$3.95M$3.63M$3.94M$3.31M$3.13M$3.22M$3.05M$3.40M
Total assets$427.74M$451.07M$513.56M$586.97M$631.24M$671.53M$741.99M$1.51B$1.58B$1.63B
Total current liabilities$60.62M$67.19M$106.83M$90.01M$112.20M$103.81M$94.86M$225.41M$173.76M$158.16M
Short-term debt$5.37M$6.31M$18.23M$7.74M$12.26M$2.20M$3.05M$436.00K$234.00K$1.64M
Long-term debt$36.03M$45.72M$49.10M$46.32M$45.92M$78.19M$76.64M$603.17M$613.53M$619.71M
Total debt$41.40M$52.04M$67.33M$54.06M$58.19M$80.39M$79.69M$603.61M$613.77M$621.35M
Total liabilities$98.48M$117.34M$149.20M$159.44M$182.51M$226.01M$213.33M$873.49M$845.17M$840.49M
Shareholders' equity$329.25M$333.74M$332.44M$381.37M$402.31M$445.52M$528.66M$639.42M$732.30M$788.80M

Cash flow

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow$38.56M$39.21M$38.19M$41.76M$57.27M$97.99M$89.18M$183.50M$213.39M$156.12M
Capital expenditures$21.38M$35.10M$46.81M$41.55M$33.85M$27.46M$24.03M$38.17M$41.04M$34.88M
Free cash flow$17.18M$4.11M-$8.62M$207.00K$23.41M$70.54M$65.15M$145.34M$172.34M$121.23M
Investing cash flow-$39.50M-$36.89M-$42.18M-$50.53M-$36.41M-$28.67M-$32.78M-$649.12M-$124.93M-$70.33M
Financing cash flow$7.14M-$7.72M$25.01M-$3.78M-$2.25M-$37.02M-$26.44M$454.09M-$80.95M-$67.42M
Share buybacks$9.91M$30.75M$25.05M$22.29M$24.43M$28.87M$39.91M$58.14M$85.46M$75.59M
Stock-based compensation$15.12M$17.09M$16.68M$17.30M$20.50M$18.69M$17.86M$20.24M$24.37M$27.28M
Depreciation & amortization$12.16M$6.42M$6.05M$7.06M$9.03M$10.22M$12.60M$25.74M$28.25M$31.65M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.